Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

Please provide your email address to receive an email when new articles are posted on . Several European studies have investigated integrating spirometry at the time of low-dose CT. Spirometry ...

New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Scientifically formulated with mullein, peppermint oil, oregano, and eucalyptus, BREATHE Drops deliver powerful natural lung ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

When was the last time you thought about your lungs unless you were short of breath or down with a cold? Most of us take our lungs for granted, but these spongy, hard-working organs do a lot more than ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

These include two respiratory indications as an add-on treatment for severe refractory ... Exacerbations are acute episodes of worsening COPD symptoms and can result in hospitalisation and ...